Clinical Trial Update: Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing HepQuant DSI with HVPG in liver disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Snippet

Sponsor: University of Colorado, Denver | Conditions: Liver Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-02-05